Global Longlife Hospital Insider Completes Third Major Share Sale in December

2 min read     Updated on 12 Dec 2025, 10:45 AM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Global Longlife Hospital insider Sucheta Jani completed her third major share sale in December 2025, disposing of 3,08,000 equity shares on December 22. Combined with her earlier transactions of 1,00,000 and 5,95,000 shares, she has sold over 10 lakh shares this month, reducing her stake from 18.00% to 7.14%. All transactions were conducted through open market sales and disclosed in compliance with SEBI regulations.

27062132

*this image is generated using AI for illustrative purposes only.

Sucheta Jani, a significant shareholder of Global Longlife Hospital & Research Limited, has disclosed her third substantial share sale in December, disposing of 3,08,000 equity shares on December 22, 2025. This latest transaction further reduces her stake in the healthcare company, marking an unprecedented series of disposals within a single month.

Latest Transaction Details

The most recent share sale occurred on December 22, 2025, through open market transactions. The disclosure was filed with BSE Limited on the same day, in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Parameter: Latest Transaction Second Transaction First Transaction
Shares Sold: 3,08,000 equity shares 5,95,000 equity shares 1,00,000 equity shares
Transaction Date: December 22, 2025 December 12-17, 2025 December 10-11, 2025
Mode of Sale: Open market Open market Open market
Filing Date: December 22, 2025 December 17, 2025 December 11, 2025

Cumulative Shareholding Impact

Following the latest transaction, Sucheta Jani's ownership position has decreased significantly from her original holding at the beginning of December. Her shareholding has now reduced from 10.07% to 7.14% of the total voting capital after the December 22 sale.

Metric: Before Latest Sale After Latest Sale Total Change
Shares Held: 10,58,000 7,50,000 -3,08,000
Voting Rights (%): 10.07% 7.14% -2.93%
Share Capital (%): 10.07% 7.14% -2.93%

December Trading Activity Summary

The three transactions in December represent a combined disposal of 10,03,000 shares, reducing Sucheta Jani's total stake from 18.00% to 7.14% within a span of just 12 days. This represents one of the most significant insider selling activities for the company.

Transaction Summary: Details
Total Shares Sold in December: 10,03,000 shares
Original Holding (December 1): 18.00% (18,90,000 shares)
Current Holding: 7.14% (7,50,000 shares)
Net Reduction: 10.86% stake
Total Value Disposed: Over ₹95.00 lakh worth of shares

Company Information

Global Longlife Hospital and Research Limited maintains a stable equity share capital structure. The company operates in the healthcare sector and its shares are listed on BSE Limited under the scrip code 543520.

Details: Specifications
Equity Share Capital: ₹10.50 crores
Total Shares: 1,05,00,000
Face Value: ₹10.00 per share
BSE Scrip Code: 543520
ISIN: INE0J2K01014
Market Cap: ₹19.15 crores

Regulatory Compliance

All three disclosures were made in accordance with SEBI regulations governing substantial acquisitions and disposals of shares. Sucheta Jani, based in Ahmedabad, Gujarat, filed the necessary documentation with BSE Limited and the company to ensure regulatory compliance. The transactions did not involve any voting rights acquired through means other than equity shares, warrants, or convertible securities.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+4.93%+3.76%+16.41%-10.25%-31.60%-83.49%
Global Longlife Hospital & Research
View in Depthredirect
like15
dislike

Global Longlife Hospital Reports Additional Stake Sale by Dhruv Sureshkumar Jani

2 min read     Updated on 12 Dec 2025, 10:45 AM
scanx
Reviewed by
Naman SScanX News Team
Overview

Global Longlife Hospital and Research Limited received another substantial shareholding disclosure from Dhruv Sureshkumar Jani for the sale of 50,000 equity shares under SEBI regulations. This follows his previous sale of 1,00,000 shares, bringing his total divestment to 1,50,000 shares and reducing his stake from 9.52% to 8.10% within a week through sequential open market transactions.

27062103

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital & Research has received another substantial acquisition disclosure from Dhruv Sureshkumar Jani regarding the sale of equity shares under SEBI regulations. Following his previous transaction in December, Jani has executed an additional sale of 50,000 equity shares between December 12, 2025 and December 17, 2025, further reducing his stake in the healthcare company.

Latest Transaction Details

The recent disclosure, filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, shows Jani's continued divestment in Global Longlife Hospital and Research Limited. This latest transaction follows his earlier sale of 1,00,000 shares completed between December 10-11, 2025.

Transaction Parameter Latest Sale Previous Sale
Shares Sold 50,000 equity shares 1,00,000 equity shares
Transaction Period December 12 - December 17, 2025 December 10 - December 11, 2025
Mode of Sale Open Market Open Market
Regulatory Filing SEBI Regulation 29(2) SEBI Regulation 29(2)

Cumulative Shareholding Impact

With the completion of both transactions, Jani's total divestment amounts to 1,50,000 equity shares within a week. His original holding of 10,00,000 shares (9.52% stake) has been reduced through these sequential sales, demonstrating a systematic reduction in his investment in the company.

Shareholding Timeline Shares Held Percentage Holding
Before December Sales 10,00,000 9.52%
After First Sale (Dec 11) 9,00,000 8.57%
After Second Sale (Dec 17) 8,50,000 8.10%
Total Shares Sold 1,50,000 -1.42%

Company Structure and Compliance

Global Longlife Hospital and Research Limited maintains its equity share capital structure at ₹10.50 crores, comprising 1,05,00,000 equity shares of ₹10.00 each. The company continues to trade on BSE under scrip code 543520 with ISIN INE0J2K01014.

Company Details Specifications
Total Equity Capital ₹10.50 crores
Number of Shares 1,05,00,000
Face Value per Share ₹10.00
BSE Scrip Code 543520
ISIN INE0J2K01014
Sector Healthcare

Regulatory Documentation

Both transactions demonstrate full compliance with SEBI's substantial acquisition regulations. Jani, operating from 25 Divine Bunglows, Science City Road, Sola, Ahmedabad, Gujarat, has submitted all required documentation to BSE Limited and the company, ensuring complete regulatory transparency for both sequential transactions. The filings maintain the company's existing capital structure while reflecting the ongoing changes in ownership pattern.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+4.93%+3.76%+16.41%-10.25%-31.60%-83.49%
Global Longlife Hospital & Research
View in Depthredirect
like19
dislike
Explore Other Articles